Multi-Society Expert Panel Consensus Guidance Regarding Clinical Assessment and Clinical Trial Endpoints in Adults With Alpha-1 Antitrypsin Deficiency–Associated Liver Disease Post author:GIBoardReview.com Post published:May 27, 2026 Post category:Society Guidelines You Might Also Like Hepatitis C Guidance 2023 Update: American Association for the Study of Liver Diseases– Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection September 29, 2023 AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn’s Disease April 2, 2021 AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease September 29, 2023
Hepatitis C Guidance 2023 Update: American Association for the Study of Liver Diseases– Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection September 29, 2023
AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn’s Disease April 2, 2021
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease September 29, 2023